Enlarged Prostate Symptoms: When Is It Time to See a Specialist?

Written and medically reviewed by Mr Ivo Dukic, Consultant Urological Surgeon | Last reviewed: 26th Oct 2026

Introduction

Enlarged prostate symptoms tend to creep up gradually, because men adapt around them without quite noticing they're doing it — and because men assume that urinary problems are simply what getting older feels like. They don't have to be.

Benign prostatic hyperplasia — BPH, or an enlarged prostate — is one of the most common conditions I treat privately in Birmingham, and also one of the most undertreated. Most of the patients I see have been managing quietly for years, often decades, before they make the decision to book an appointment. By the time they do, they are genuinely surprised that options exist which could have made the last several years considerably more comfortable.

This article explains what enlarged prostate symptoms look like, how they are measured, what the risk of leaving them untreated is, and — most importantly — when the right time is to stop waiting and get assessed.

What Is Benign Prostatic Hyperplasia (BPH)?

The prostate is a walnut-sized gland that sits directly below the bladder and surrounds the urethra — the tube through which urine passes from the bladder to exit the body. Its primary function is to produce seminal fluid, but its anatomical position means that when it grows, it can squeeze the urethra and obstruct the free flow of urine.

BPH is not cancer. The two conditions are unrelated, though they can occasionally coexist. BPH is a non-cancerous or benign enlargement of the prostate that occurs in the majority of men as they age. By the age of 60, approximately 50% of men have histological evidence of BPH.¹ By 85, that figure is over 90%.¹˒²

The prostate grows in two main directions: outward, where it becomes palpable on examination, and inward, where it compresses the urethral channel. It is the inward growth — sometimes called the median lobe, or intravesical protrusion — that causes the most significant urinary symptoms.

What Are the Symptoms of an Enlarged Prostate?

BPH symptoms are typically grouped into two categories: voiding symptoms (problems with the act of passing urine) and storage symptoms (problems with how the bladder stores urine between voids). Most patients with BPH experience a mixture of both.³

Voiding symptoms — problems with flow:

Hesitancy: A delay between wanting to pass urine and the flow actually starting. Some men describe standing at the toilet for 30–60 seconds before anything happens. This is one of the earliest and most characteristic symptoms of bladder outflow obstruction.

Weak or slow stream: The force and calibre of the urinary stream reduces over time. Men often adapt by leaning forward, straining, or choosing cubicles over urinals.

Intermittency: The stream starts and stops unpredictably — stuttering rather than flowing continuously.

Straining: Having to push or bear down to initiate or maintain flow.

Terminal dribbling: A prolonged dribble at the end of voiding that is difficult to control and can cause embarrassment.

Incomplete emptying: The persistent sensation after urination that the bladder has not fully emptied. This is clinically significant — residual urine left in the bladder increases infection risk and, over time, can affect bladder and kidney function.³

Storage symptoms — problems between voids:

Frequency: Needing to pass urine more often than usual — typically more than every 2 hours during the day.

Urgency: A sudden, compelling need to urinate that is difficult to defer. Some men describe urgency as "running" rather than "walking" to the toilet. Urgency can progress to urge incontinence — not making it in time.

Nocturia: Waking one or more times at night to pass urine. This is often the symptom that patients find most disruptive to daily life. One episode of nocturia per night is common in older men; two or more consistently is significant and warrants assessment.⁴

Other symptoms:

Post-micturition dribble — leakage immediately after leaving the toilet

Reduced bladder sensation — a paradoxical loss of the normal urge to urinate, which can lead to very high bladder volumes going unnoticed

It is important to note that these symptoms are not exclusively caused by BPH. Overactive bladder, urinary tract infections, diabetes, neurological conditions and certain medications can all produce a similar picture.³ A specialist assessment is required to determine the underlying cause — particularly before any treatment is considered.

How Do You Measure Prostate Symptoms? The IPSS Score

One of the most useful tools in my consultation room is a short questionnaire that takes about two minutes to complete. It is called the International Prostate Symptom Score — the IPSS — and it is the international standard for measuring the severity of lower urinary tract symptoms (LUTS) caused by BPH.⁵˒⁶

The IPSS asks seven questions about the frequency of your urinary symptoms over the past month, each scored from 0 (not at all) to 5 (almost always). An eighth question asks about quality of life — how you would feel if your current urinary symptoms were to remain unchanged for the rest of your life. The total symptom score ranges from 0 to 35.⁵

Scoring interpretation:

0–7 (mild): symptoms present but not significantly affecting daily life

8–19 (moderate): symptoms having a meaningful impact — the range where treatment is most commonly started

20–35 (severe): symptoms causing significant disruption to daily life, sleep or social activities

A quality of life score of 3 or above (roughly: "mostly dissatisfied" or worse) is a reliable indicator that symptoms have crossed the threshold where treatment should be discussed, regardless of the total symptom score.⁵

Complete the IPSS symptom checker →

Your score gives both of us a reliable, validated baseline. It means we can track whether symptoms are progressing over time, and whether treatment — medical or surgical — is having the intended effect. I use it at every BPH consultation and follow-up.

If your score is 8 or above, or if your quality of life score is mostly dissatisfied or worse, I would encourage you to make an appointment rather than continue monitoring at home.

The Risk of Doing Nothing

There is a tempting logic in waiting. The symptoms came on gradually; they are manageable; the thought of seeing a doctor about urinary problems is not appealing; and perhaps things will stabilise on their own.

The medical reality is more nuanced — and sometimes more concerning.

BPH tends to progress. Multiple large studies, including the long-term data from the Medical Therapy of Prostatic Symptoms (MTOPS) trial, show that a significant proportion of men with moderate-to-severe LUTS experience symptom progression over time if untreated.⁷˒⁹ In older men with moderate or severe symptoms, the risk of acute urinary retention — a sudden, complete inability to urinate — is roughly 1 in 10 over ten years.⁸ This is a urological emergency requiring catheterisation.

Bladder changes accumulate. Chronic bladder outflow obstruction changes the bladder wall. The detrusor muscle — responsible for contracting to expel urine — thickens, becomes overactive, and eventually, in some patients, decompensates.¹⁰ There is growing concern that a bladder which has strained against obstruction for many years may not fully recover its function once the obstruction is relieved — one reason specialists increasingly favour treating earlier, when treatment is indicated.

Incomplete bladder emptying increases infection risk. Significant post-void residual urine provides a reservoir for bacterial growth. Men who do not empty their bladders fully are more prone to urinary tract infections.

Nocturia has real health consequences. It is easy to dismiss disturbed sleep as an inconvenience. The evidence says otherwise. Nocturia is associated with falls and fractures in older people, and with significantly reduced quality of life.¹¹˒¹²˒¹³ A systematic review and meta-analysis demonstrated that nocturia is associated with a relative risk of mortality of 1.27 (95% CI 1.16–1.40).¹⁴ Treatment of nocturia from BPH often produces a more dramatic improvement in wellbeing than patients anticipated before they were treated.

When Is It Time to See a Specialist?

This is the question I am asked most often, and my answer is almost always: sooner than you think.

See a specialist promptly if any of the following apply:

- You are waking more than once per night to pass urine on a regular basis

- You experience urgency — the sudden, difficult-to-defer need to urinate

- You have had any episode of urinary incontinence (not making it to the toilet in time)

- Your IPSS score is 8 or above

- Your quality of life score on the IPSS is 3 or above (mostly dissatisfied or worse)

- Your symptoms are affecting your work, social life, travel, exercise or sleep

- You have stopped doing things you would otherwise do — avoiding long car journeys, skipping social events, avoiding exercise — because of your urinary symptoms

See a specialist urgently (same day or emergency) if:

- You cannot pass urine at all — this is acute urinary retention and requires immediate hospital assessment

- You have visible blood in your urine — this requires investigation to rule out bladder cancer, regardless of whether you have BPH

- You have pain when passing urine alongside urinary symptoms — this suggests infection and needs prompt assessment

- You have a fever alongside urinary symptoms — again, infection, and potentially serious

A note on self-management

Mild symptoms (IPSS 0–7) with no significant quality of life impact can reasonably be monitored with lifestyle measures — reducing caffeine and alcohol, avoiding fluid loading in the evening, double voiding, and bladder training. These measures can provide modest relief for mild BPH.³ They are not a substitute for specialist assessment in anyone with moderate or severe symptoms, and they do not address the underlying obstruction.

What Happens at a BPH Assessment?

Patients often tell me they were unsure what to expect at their first urology appointment. Understanding the process makes it considerably less daunting.

At your initial consultation, I will:

- Take a detailed history of your urinary symptoms, including their duration, progression, and impact on your life

- Review your IPSS score if you have completed it in advance

- Ask about your general health, medications, fluid intake, and relevant surgical history

- Perform a digital rectal examination where clinically appropriate — a brief, straightforward examination that takes less than a minute and gives valuable information about prostate size and consistency

- Review any existing test results — urine flow rate, post-void residual volume ultrasound, PSA blood test, urinalysis

In most cases, I will arrange or review:

Flow rate study (uroflowmetry): A non-invasive test in which you pass urine into a machine that measures the speed and pattern of your flow. A peak flow rate below about 10 ml/second makes obstruction more likely, although a weak bladder muscle can produce a similar result.³

Post-void residual ultrasound: An ultrasound scan immediately after urination to measure the volume of urine remaining in the bladder. A raised residual volume is tracked over time and helps guide treatment decisions.³

PSA blood test: Requested in appropriate patients to give additional information about prostate health. A raised PSA does not diagnose cancer, but it can influence management decisions including the type of treatment recommended.

Prostate ultrasound or MRI scan of the prostate: Measurement of prostate volume, which influences the choice of surgical treatment if surgery is ultimately recommended.

At the end of the consultation, you will have a clear diagnosis, an understanding of the severity of your obstruction, and a personalised discussion of treatment options ranging from lifestyle modification through to surgery.

What Are the Treatment Options for an Enlarged Prostate?

Treatment decisions for BPH are made based on your symptom severity, prostate size, flow rate, post-void residual volume, and personal priorities — particularly your views on recovery time and the preservation of sexual function.

Watchful waiting

Appropriate for mild symptoms (IPSS 0–7) with good quality of life and no significant obstruction on objective testing. Regular monitoring to check for progression.³

Medication

Alpha-blockers (tamsulosin, alfuzosin, silodosin): Relax the smooth muscle of the prostate and bladder neck, improving flow relatively quickly. Improvement can start within days, although the full effect takes a few weeks.³ Do not shrink the prostate — symptoms return if medication is stopped.

5-alpha reductase inhibitors (finasteride, dutasteride): Shrink the prostate over 6–12 months by blocking dihydrotestosterone.¹⁵ Most effective in larger prostates. Can cause sexual side effects including reduced libido, ejaculatory changes and depression in some men.

Combination therapy: Alpha-blocker plus 5-alpha reductase inhibitor — most effective for larger prostates with significant symptoms. Evidence from the MTOPS trial supports long-term benefit over either agent alone.⁷˒¹⁶

Anticholinergics / beta-3 agonists: For predominantly storage symptoms (urgency, frequency, nocturia) where overactive bladder is a significant component.³

Medication manages symptoms rather than removing the underlying obstruction. Some men find their symptoms progress despite medication, or would rather not take tablets long term, and go on to discuss surgical options.

Surgery for BPH

When symptoms are moderate to severe and not adequately controlled by medication, or when a patient prefers definitive treatment, surgery is discussed. The main surgical options are:

TURP (Transurethral Resection of the Prostate): The established surgical standard for several decades. Effective and durable, but associated with higher rates of retrograde ejaculation (65–90%)¹⁷ and a small risk of incontinence. Requires general or spinal anaesthetic and a 1–2 night hospital stay.

HoLEP (Holmium Laser Enucleation of the Prostate): Highly effective for large prostates. Lower bleeding risk than TURP, suitable for patients on anticoagulation. Skilled and specialised procedure. I currently refer patients to other specialists for this procedure.

Aquablation therapy: A minimally invasive, robotic, heat-free procedure using the AquaBeam system. NICE-approved (IPG770).¹⁸ Particularly well-suited for men who wish to preserve ejaculatory and erectile function — clinical trial data (WATER trial) showed loss of ejaculation in approximately 10% of sexually active men, versus 36% after TURP.¹⁹ Clinical trials have studied prostates of approximately 30–150cc. Available privately at The Harborne Hospital, Birmingham.

Full guide to Aquablation therapy at The Harborne Hospital, Birmingham →

The right operation for you depends on your prostate size and shape, your symptom severity, your priorities around sexual function and recovery time, and your general health. I offer a range of options at my practice, which means my recommendation is always based on what is genuinely best for your situation — not what happens to be available.

Why Act Now Rather Than Wait?

When I ask patients why they delayed seeking help, the answers are usually some version of: "I thought it was just part of getting older" or "I didn't want to make a fuss."

Effective treatment exists. The range of options for BPH has expanded substantially in the past ten years — we now have procedures that were not available to previous generations, including techniques that treat the obstruction while substantially preserving sexual function.

The bladder may not fully bounce back. There is growing concern that a detrusor muscle that has worked against obstruction for many years recovers less completely than one treated earlier.¹⁰ Assessing and treating in good time — when it is indicated — gives the bladder the best chance.

Quality of life matters. The men who tell me they are "managing fine" with nocturia twice a night, urgency every two hours, and a stream that takes a minute to start are not managing fine — they are accommodating a condition that has steadily taken things from them.

A single 30-minute consultation can tell you where you stand, what your options are, and whether your symptoms are significant enough to treat. That is not a large investment against years of unnecessarily compromised quality of life.

Assess Your Symptoms Now

The IPSS questionnaire takes approximately two minutes and gives you a validated, clinically meaningful score for your symptoms:⁵

Complete the International Prostate Symptom Score →

A score of 8 or above, or a quality of life score of 3 or above, is a reliable indicator that a specialist consultation is worthwhile.

Book a Private BPH Consultation in Birmingham

I see patients with urinary symptoms and BPH privately at four hospital sites across Birmingham, Solihull and Worcestershire. Initial consultations are available within 7 days in most cases.

Call: 0121 716 9046 — Monday to Friday, 8am–6pm

Email: admin@ivodukic.co.uk

Online booking:

The Harborne Hospital (HCA Healthcare) →

The Priory Hospital or Droitwich Spa (Circle Health) →

The Spire Parkway Hospital, Solihull (Spire Healthcare)→

Initial consultation fee: £300 for 30 minutes

Fee-assured with BUPA, AXA PPP, Aviva, Vitality, WPA, Cigna, AIG and Aetna. No GP referral required.

Full information on private urology appointments in Birmingham →

Frequently Asked Questions

Is an enlarged prostate the same as prostate cancer?

No. Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate. It does not become cancer and does not increase your risk of developing prostate cancer. The two conditions are unrelated, though they can occasionally coexist in the same patient. Both can raise PSA levels, which is one reason a raised PSA requires careful interpretation rather than automatic assumption of cancer.

At what age do enlarged prostate symptoms typically start?

BPH can begin to cause symptoms from the mid-40s onward, though most men first notice significant symptoms in their 50s and 60s.¹ By age 70, the majority of men have some degree of urinary symptoms related to prostate enlargement. The age of onset varies widely — some men in their 40s have significant obstruction; others in their 70s remain largely asymptomatic.²

Will my symptoms get worse without treatment?

Often, yes. Studies show that a significant proportion of men with moderate or severe BPH experience symptom progression over time without treatment.⁷ In older men with moderate or severe symptoms, the risk of acute urinary retention — a sudden inability to urinate — is roughly 1 in 10 over ten years.⁸ The bladder also undergoes gradual changes in response to chronic obstruction that can affect its long-term function.¹⁰ This is one reason specialists increasingly favour earlier treatment when it is indicated.

Can BPH cause permanent kidney damage?

If BPH causes severe, prolonged obstruction, it can — in rare cases — lead to hydronephrosis (back-pressure on the kidneys) and, over years, chronic kidney disease. This is uncommon in men who receive appropriate assessment and treatment, but it does underscore the importance of not ignoring progressive or severe urinary symptoms indefinitely.³

Does Aquablation preserve sexual function?

Aquablation is specifically designed to minimise sexual side effects compared to conventional prostate surgery. In the pivotal WATER clinical trial, loss of ejaculation occurred in approximately 10% of sexually active men after Aquablation, compared to 36% after TURP.¹⁹ Erectile dysfunction and urinary incontinence rates were low in both groups. No surgical procedure carries zero risk, and outcomes depend on individual anatomy — I discuss realistic individual expectations at your pre-operative consultation.

Full guide to Aquablation therapy →

Do I need a GP referral to see a private urologist about my prostate symptoms?

No. You can self-refer directly to my practice by calling 0121 716 9046 or booking online. A GP letter is welcome and helpful if you have existing test results — PSA, flow rate studies, or a prostate ultrasound — but it is not required to arrange a private consultation.

What is a normal PSA for my age?

PSA levels naturally rise with age and prostate size, and BPH itself raises PSA without any cancer being present. There is no single "normal" PSA number — interpretation depends on your age, prostate volume, rate of change over time (PSA velocity) and individual risk factors. A raised PSA should be discussed with a urologist rather than interpreted in isolation. I cover this in more detail on the PSA testing page →

References

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.

2. Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, et al. (eds). Campbell's Urology. 8th ed. Philadelphia: Saunders; 2002.

3. European Association of Urology. EAU Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms (LUTS). Edn. presented at the EAU Annual Congress London 2026. Arnhem: EAU Guidelines Office; 2026. Available from: uroweb.org/guidelines/management-of-non-neurogenic-male-luts

4. Weiss JP, Blaivas JG, Jones M, Wang JT, Guan Z. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol. 2007;178(2):548–51.

5. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57.

6. Yao MW, Green JSA. How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self-administered patient questionnaire for male lower urinary tract symptoms. Low Urin Tract Symptoms. 2022;14(2):92–101.

7. McConnell JD, Roehrborn CG, Bautista OM, et al; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387–98.

8. Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol. 1999;162(2):376–82.

9. Emberton M, Andriole GL, de la Rosette J, et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology. 2003;61(2):267–73.

10. Kuang WW, Cindolo L, Alsaody T, Chughtai BI. Tackling the progression of benign prostatic hyperplasia/benign prostatic obstruction progression: deobstructing within the "window of curability" (a hypothesis-generating review). Curr Urol. 2025;19(6):388–95. doi:10.1097/CU9.0000000000000299

11. Pesonen JS, Vernooij RWM, Cartwright R, Aoki Y, Agarwal A, Mangera A, et al. The impact of nocturia on falls and fractures: a systematic review and meta-analysis. J Urol. 2020;203(4):674–83.

12. Nakagawa H, Niu K, Hozawa A, et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184(4):1413–8.

13. Weiss JP, Everaert K. Management of nocturia and nocturnal polyuria. Urology. 2019;133S:24–33.

14. Pesonen JS, Cartwright R, Vernooij RWM, Aoki Y, Agarwal A, Mangera A, et al. The impact of nocturia on mortality: a systematic review and meta-analysis. J Urol. 2020;203(3):486–95.

15. Roehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int. 2008;101 Suppl 3:17–21.

16. Roehrborn CG, Siami P, Barkin J, et al; CombAT Study Group. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123–31.

17. Marra G, Sturch P, Oderda M, Tabatabaei S, Muir G, Gontero P. Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: time for a bespoke approach? Int J Urol. 2016;23(1):22–35.

18. National Institute for Health and Care Excellence (NICE). Transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia. Interventional Procedures Guidance [IPG770]. London: NICE; 2023.

19. Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. WATER: a double-blind, randomized, controlled trial of Aquablation vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol. 2018;199(5):1252–61.

Ivo Dukic

Contacts

e-mail: admin@ivodukic.co.uk

Telephone number for private patients:

0121 716 9046
(Mondays to Fridays 0800 - 18:00)

Birmingham Urology Centre

For NHS patients seen at University Hospitals Birmingham NHS Hospitals please get in contact on

0121 424 9011

(Mondays to Fridays 0900 - 17:00)

ivodukic.co.uk

© 2026 UrolSurg LTD · Privacy policy

GMC 6103172

BSc MBChB PG Cert FRCSEd (Urol)